GEGAX
Price
$17.19
Change
-$0.04 (-0.23%)
Updated
Nov 19 closing price
Net Assets
910.16M
VEIEX
Price
$34.03
Change
-$0.05 (-0.15%)
Updated
Nov 19 closing price
Net Assets
141.19B
Interact to see
Advertisement

GEGAX vs VEIEX

Header iconGEGAX vs VEIEX Comparison
Open Charts GEGAX vs VEIEXBanner chart's image
abrdn Emerging Markets A
Price$17.19
Change-$0.04 (-0.23%)
VolumeN/A
Net Assets910.16M
Vanguard Emerging Mkts Stock Idx I
Price$34.03
Change-$0.05 (-0.15%)
VolumeN/A
Net Assets141.19B
GEGAX vs VEIEX Comparison Chart in %
View a ticker or compare two or three
VS
GEGAX vs. VEIEX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GEGAX is a Hold and VEIEX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEIEX has more cash in the bank: 141B vs. GEGAX (910M). VEIEX pays higher dividends than GEGAX: VEIEX (2.61) vs GEGAX (0.90). GEGAX was incepted earlier than VEIEX: GEGAX (14 years) vs VEIEX (32 years). GEGAX (1.43) is less costly to investors than VEIEX (0.29). GEGAX is a more actively managed with annual turnover of: 33.00 vs. VEIEX (8.00). VEIEX has a lower initial minimum investment than GEGAX: VEIEX (0) vs GEGAX (1000). GEGAX annual gain was more profitable for investors over the last year : 25.42 vs. VEIEX (20.18). VEIEX return over 5 years is better than : 23.38 vs. GEGAX (-4.32).
GEGAXVEIEXGEGAX / VEIEX
Total Expense Ratio1.400.29483%
Annual Report Gross Expense Ratio1.430.29493%
Fund Existence14 years32 years-
Gain YTD28.39022.205128%
Front Load6%N/A-
Min. Initial Investment10000-
Min. Initial Investment IRA1000N/A-
Net Assets910M141B1%
Annual Yield % from dividends0.902.6135%
Returns for 1 year25.4220.18126%
Returns for 3 years41.4547.2388%
Returns for 5 years-4.3223.38-18%
Returns for 10 years52.0678.6166%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CUE0.58N/A
+0.02%
Cue Biopharma
RNGR13.51N/A
N/A
Ranger Energy Services
MTSR70.50N/A
N/A
Metsera Inc
CHPGU10.26N/A
N/A
Championsgate Acquisition Corp
TRVI11.05-0.26
-2.30%
Trevi Therapeutics